← Back to guidelines
Allergy & Immunology559 papers

IgE-mediated allergic asthma

Last edited: 4/14/2026

Overview

IgE-mediated allergic asthma is a chronic inflammatory airway disease characterized by bronchial hyperresponsiveness and reversible airflow obstruction, triggered by allergens that induce IgE-mediated immune responses 1.

Diagnosis

  • Clinical History: Detailed history of allergen exposure and symptoms (e.g., wheezing, coughing, shortness of breath) 1.
  • Physical Examination: Focus on respiratory signs (e.g., wheezing, prolonged expiration) 1.
  • Allergy Testing: Skin prick tests or specific IgE blood tests to identify specific allergens 1.
  • Pulmonary Function Tests: Spirometry to assess airflow obstruction and reversibility 1.
  • Avoid Unnecessary Testing: Judicious use of diagnostic tests, avoiding routine vitamin D testing unless clinically indicated 1.
  • Management

  • First-Line Treatments:
  • - Inhaled Corticosteroids (ICS): Daily use to reduce airway inflammation (specific doses vary by patient) 1. - Short-Acting Beta-Agonists (SABA): As needed for acute symptoms 1.
  • Adjunctive Treatments:
  • - Long-Acting Beta-Agonists (LABA): Combined with ICS for better control in moderate to severe cases 1. - Leukotriene Receptor Antagonists (LTRA): As add-on therapy if ICS/LABA insufficient 1. - Biologics: For severe persistent asthma uncontrolled by standard therapy (e.g., omalizumab for IgE-mediated asthma) 1.

    Special Populations

  • Pediatrics: Tailored dosing of ICS and close monitoring for growth effects 1.
  • Elderly: Increased vigilance for comorbidities and polypharmacy interactions 1.
  • Pregnancy: Focus on minimizing ICS use while maintaining asthma control; consult guidelines for specific recommendations 1.
  • Key Recommendations

  • Apply Ockham's razor in diagnosis, prioritizing thorough clinical history and examination before extensive testing 1.
  • Use focused allergy/immunology testing judiciously and avoid routine vitamin D testing in poorly controlled allergic diseases 1.
  • Implement a collaborative approach to teaching and assessing core competencies in allergy/immunology training programs 3.
  • (Evidence: Expert opinion)

    References

    1 Warner JO. Ockham's Razor: The Application of Parsimonious Medicine in Allergy/Immunology. The journal of allergy and clinical immunology. In practice 2024. link 2 Dinakarpandian D, Lee Y, Dinakar C. Applications of medical informatics in allergy/immunology. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2007. link60613-8) 3 Reed VA, Jernstedt GC, Ballow M, Bush RK, Gewurz AT, McGeady SJ. Developing resources to teach and assess the core competencies: a collaborative approach. Academic medicine : journal of the Association of American Medical Colleges 2004. link 4 Losonczy S, Szabó C, Kiss Z, Bárdos L. Application of an anti-HQIgY antibody for the measurement of IgY concentrations of hen's and quail's serum and yolk. Acta physiologica Hungarica 1999. link 5 Mattiasson B, Håkanson H. Immunochemically based assays for process control. Advances in biochemical engineering/biotechnology 1992. link

    Original source

    1. [1]
      Ockham's Razor: The Application of Parsimonious Medicine in Allergy/Immunology.Warner JO The journal of allergy and clinical immunology. In practice (2024)
    2. [2]
      Applications of medical informatics in allergy/immunology.Dinakarpandian D, Lee Y, Dinakar C Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology (2007)
    3. [3]
      Developing resources to teach and assess the core competencies: a collaborative approach.Reed VA, Jernstedt GC, Ballow M, Bush RK, Gewurz AT, McGeady SJ Academic medicine : journal of the Association of American Medical Colleges (2004)
    4. [4]
      Application of an anti-HQIgY antibody for the measurement of IgY concentrations of hen's and quail's serum and yolk.Losonczy S, Szabó C, Kiss Z, Bárdos L Acta physiologica Hungarica (1999)
    5. [5]
      Immunochemically based assays for process control.Mattiasson B, Håkanson H Advances in biochemical engineering/biotechnology (1992)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG